Company: Amgen Inc.
Job title: Principal Scientist
Exploring the Development of AMG 133: Utilizing GLP-1 Agonist Peptides to Tackle Obesity 12:00 pm
Exploring site-specific conjugation of peptides to monoclonal antibodies Improving metabolic stability of bispecific conjugates through antibody and peptide engineering Identifying clinical candidate for the treatment of obesity using preclinical modelsRead more
day: Pre-Conference Day Track 1